Ufp Technologies Inc UFPT
We take great care to ensure that the data presented and summarized in this overview for UFP TECHNOLOGIES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding UFPT
View all-
Black Rock Inc. New York, NY1.07MShares$212 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT577KShares$115 Million0.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA557KShares$111 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY443KShares$88.3 Million0.09% of portfolio
-
State Street Corp Boston, MA296KShares$59.1 Million0.0% of portfolio
-
Congress Asset Management CO281KShares$56.1 Million0.48% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny279KShares$55.6 Million0.11% of portfolio
-
Dimensional Fund Advisors LP Austin, TX180KShares$35.8 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD178KShares$35.6 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA175KShares$34.9 Million0.01% of portfolio
Latest Institutional Activity in UFPT
Top Purchases
Top Sells
About UFPT
UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Insider Transactions at UFPT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Jason Holt Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-5.56%
|
$99,330
$215.24 P/Share
|
|
Mar 03
2025
|
Steve Cardin Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
623
-9.97%
|
$133,945
$215.24 P/Share
|
|
Mar 03
2025
|
Ronald J Lataille Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,034
-13.53%
|
$437,310
$215.24 P/Share
|
|
Mar 03
2025
|
Mitchell Rock President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,523
-7.1%
|
$542,445
$215.24 P/Share
|
|
Mar 03
2025
|
Christopher P. Litterio Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
921
-6.15%
|
$198,015
$215.24 P/Share
|
|
Mar 03
2025
|
R Jeffrey Bailly CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,805
-6.05%
|
$2,108,075
$215.24 P/Share
|
|
Feb 28
2025
|
Cynthia L Feldmann Director |
SELL
Open market or private sale
|
Direct |
2,756
-21.16%
|
$636,636
$231.08 P/Share
|
|
Feb 28
2025
|
Cynthia L Feldmann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,756
+28.83%
|
$104,728
$38.61 P/Share
|
|
Feb 27
2025
|
Daniel C Croteau Director |
SELL
Open market or private sale
|
Direct |
6,846
-17.53%
|
$1,567,734
$229.28 P/Share
|
|
Feb 27
2025
|
Ronald J Lataille Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
400
+2.59%
|
$91,600
$229.09 P/Share
|
|
Feb 11
2025
|
Christopher P. Litterio Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
2,149
+6.92%
|
-
|
|
Feb 11
2025
|
Steve Cardin Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
1,207
+9.24%
|
-
|
|
Feb 11
2025
|
Jason Holt Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
1,589
+9.09%
|
-
|
|
Feb 11
2025
|
Mitchell Rock President |
BUY
Grant, award, or other acquisition
|
Direct |
6,332
+8.53%
|
-
|
|
Feb 11
2025
|
R Jeffrey Bailly CEO |
BUY
Grant, award, or other acquisition
|
Direct |
21,655
+6.47%
|
-
|
|
Feb 11
2025
|
Ronald J Lataille Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,958
+18.61%
|
-
|
|
Dec 20
2024
|
R Jeffrey Bailly CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
806
-0.57%
|
$203,112
$252.85 P/Share
|
|
Dec 20
2024
|
R Jeffrey Bailly CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,582
+1.11%
|
-
|
|
Nov 13
2024
|
R Jeffrey Bailly CEO |
SELL
Open market or private sale
|
Indirect |
2,488
-2.04%
|
$860,848
$346.95 P/Share
|
|
Nov 12
2024
|
Jason Holt Vice President |
SELL
Open market or private sale
|
Direct |
146
-2.13%
|
$49,932
$342.69 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 41.9K shares |
|---|---|
| Exercise of conversion of derivative security | 6.49K shares |
| Open market or private purchase | 400 shares |
| Open market or private sale | 159K shares |
|---|---|
| Payment of exercise price or tax liability | 17.2K shares |
| Bona fide gift | 1.5K shares |